Yingfen Chen
State Key Laboratory Of Drug Research
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Sinusoidal endothelial cells control liver inflammation and fibrosis.
Journal: The Journal of clinical investigation
Published: June 01, 2026
Macrophage NEDD4L restrains liver fibrosis by preventing scar-associated macrophage expansion via ubiquitination of phospho-SMAD3.
Journal: International journal of biological sciences
Published: October 13, 2025
ANXA1-FPR1 signaling in myeloid cells drives MASH by elevating S100A4/A11.
Journal: JHEP reports : innovation in hepatology
Published: September 05, 2025
Hepatic IκBζ promotes alcohol-associated liver disease and acute hepatitis by enhancing CXCL1-Mediated neutrophil infiltration.
Journal: Free radical biology & medicine
Published: April 09, 2025
Immunopathogenic mechanisms and immunoregulatory therapies in MASLD.
Journal: Cellular & molecular immunology
Published: March 31, 2025
Interleukin-19 ameliorates drug-induced liver injury by limiting proinflammatory macrophage infiltration via SUMOylation of C/EBPβ.
Journal: Journal of hepatology
Published: March 19, 2025
Hepatic microRNA-320 restrains ferroptosis to mitigate acute-on-chronic alcohol-induced liver injury.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 04, 2024
Downregulation of ubiquitous microRNA-320 in hepatocytes triggers RFX1-mediated FGF1 suppression to accelerate MASH progression.
Journal: Acta pharmaceutica Sinica. B
Published: June 18, 2024
Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets.
Journal: Seminars in liver disease
Published: June 05, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026